Add to ORKGAspirin in a daily dose of 160 to 300 mg initiated within 48 hours of symptom onset results in a net decrease in morbidity and mortality caused by acute ischemic stroke (Strength of Recommendation [SOR]: A, based on a systematic review), regardless of the availability of computed tomography (CT). (SOR: A, based on a meta-analysis). Aspirin is as effective as anticoagulants in this regard and causes less harm (SOR: A, based on a systematic review), but it should not be used in patients receiving thrombolytic therapy. (SOR: B, based on one randomized controlled trial [RCT])
Aspirin reduces the occurrence of ischemic strokes. In some prophylactic trials it was suggested tha...
Background: Aspirin is recommended for secondary prevention after transient ischaemic attack (TIA) o...
Background: Thrombolysis with rt-PA is the only approved pharmacological therapy for acute ischemic ...
BACKGROUND AND PURPOSE: Long-term daily aspirin is of benefit in the years after ischemic stroke, an...
Acute ischemic stroke is characterized by sudden loss of arterial blood supply to cerebral tissue, o...
Summary: A questionnaire was sent to all 155 consultant physicians and geriatricians in the Yorkshir...
OBJECTIVE: To evaluate the efficacy of aspirin for the treatment and prevention of ischemic stroke a...
Background and Purpose—Although the efficacy of aspirin in reducing stroke incidence is clear, its r...
BackgroundIn people with acute ischaemic stroke, platelets become activated and can cause blood clot...
Background and Purpose: In patients with acute mild-moderate ischemic stroke or high-risk transient ...
BACKGROUND Ticagrelor may be a more effective antiplatelet therapy than aspirin for the prevention o...
Item does not contain fulltextBACKGROUND: Antiplatelet treatment with aspirin and oral anticoagulant...
BACKGROUND: Aspirin is recommended for secondary prevention after transient ischaemic attack (TIA) o...
Importance: Reduction of subsequent disabling stroke is the main goal of preventive treatment in the...
There is no evidence that anticoagulation with warfarin, initiated after a non- cardioembolic ischem...
Aspirin reduces the occurrence of ischemic strokes. In some prophylactic trials it was suggested tha...
Background: Aspirin is recommended for secondary prevention after transient ischaemic attack (TIA) o...
Background: Thrombolysis with rt-PA is the only approved pharmacological therapy for acute ischemic ...
BACKGROUND AND PURPOSE: Long-term daily aspirin is of benefit in the years after ischemic stroke, an...
Acute ischemic stroke is characterized by sudden loss of arterial blood supply to cerebral tissue, o...
Summary: A questionnaire was sent to all 155 consultant physicians and geriatricians in the Yorkshir...
OBJECTIVE: To evaluate the efficacy of aspirin for the treatment and prevention of ischemic stroke a...
Background and Purpose—Although the efficacy of aspirin in reducing stroke incidence is clear, its r...
BackgroundIn people with acute ischaemic stroke, platelets become activated and can cause blood clot...
Background and Purpose: In patients with acute mild-moderate ischemic stroke or high-risk transient ...
BACKGROUND Ticagrelor may be a more effective antiplatelet therapy than aspirin for the prevention o...
Item does not contain fulltextBACKGROUND: Antiplatelet treatment with aspirin and oral anticoagulant...
BACKGROUND: Aspirin is recommended for secondary prevention after transient ischaemic attack (TIA) o...
Importance: Reduction of subsequent disabling stroke is the main goal of preventive treatment in the...
There is no evidence that anticoagulation with warfarin, initiated after a non- cardioembolic ischem...
Aspirin reduces the occurrence of ischemic strokes. In some prophylactic trials it was suggested tha...
Background: Aspirin is recommended for secondary prevention after transient ischaemic attack (TIA) o...
Background: Thrombolysis with rt-PA is the only approved pharmacological therapy for acute ischemic ...